< img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=193230433501042&ev=PageView&noscript=1"/>

KNOWLEDGE CENTER

Know more about PTCA Balloon catheter, Inflation Device Manufacturer

You are here: Home » Knowledge Center » Company News » Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate!

Good news! Octoparms® Ⅱ Vena Cava Filter Obtained NMPA Certificate!

Views: 0     Author: Site Editor     Publish Time: 2025-03-27      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary Mixin Medtech was also approved by the National Medical Products Administration (NMPA) today. (registration number is 20253030586).

微信图片_20250314153801

Vena Cava Filter

Three core advantages upgraded


The stability upgraded

  • Retrieval hook is smooth to reduce delivery resistance

  • Raise and widen the balance arm to improve long-term stability

  • New anchoring hook design, anti-displacement, anti-penetration

  • Diamond-shaped filter can effectively block thrombus of 4mm and above


The specification upgraded

微信图片_20250325174308


The delivery system upgraded

  • Releasable and interlocking arm design, to achieve controlled release in a transjugular way

  • Double markers with a space of 30mm, help measure the diameter of the inferior vena cava

  • The sheath is braided to enhance support and bending resistance and establish a stable path

  • The sheath end is thread design, anti-shift, easy to approach


The delivery system

微信图片_20250327125542

Octoparms® vena cava filter, clinically proven, is a domestic umbrella-shaped filter with excellent performance, it has been recognized by nearly 2,000 hospitals in China since its launch, benefiting tens of thousands of patients.

Coming out of the clinic need and serving the clinic need, Octoparms® Ⅱ, an upgrade of the Octoparms® vena cava filter, will be more widely used and accepted for the benefit of more patients


QUICK LINKS

PRODUCTS CATEGORY

GET IN TOUCH

 2F-3F, Building 6, No.8 Jinfeng Road, Suzhou New District, 215163, P.R. China. 
+86-512-8717-4080
+86-512-8717-4081
 market@kosselmed.com

CONTACT US

Feedback
Copyright © 2022 Kossel Medtech (Suzhou) Co., Ltd. Support by Leadong  Sitemap